Clinical Trials Browser

Phase 2 × INDUSTRY × epothilone B × Clear all

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00411528 2020-12-17

Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer

Phase 2 Completed

185 enrolled

Genitourinary

Prostatic Neoplasms

NCT00050349 2017-03-01

EPO906 in Carcinoid and Other Neuroendocrine Tumors

Phase 2 Completed

33 enrolled

EndocrineNET

Carcinoid Tumor, Carcinoma, Vipoma, Neoplasm Metastasis, Neoplasms, Gastrinoma, Neuroendocrine Tumors

NCT00035113 2017-02-09

EPO906 Therapy in Patients With Prostate Cancer

Phase 2 Completed

48 enrolled

Genitourinary

Carcinoma, Neoplasms, Prostatic Neoplasms

NCT00035126 2017-02-08

EPO906 Therapy in Patients With Advanced Breast Cancer

Phase 2 Completed

46 enrolled

Breast

Breast Neoplasms, Neoplasms

NCT00273312 2017-02-07

Patupilone Activity in Advanced/Metastatic Hepatocellular Carcinoma

Phase 2 Completed

25 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00035087 2013-12-04

EPO906 Therapy in Patients With Advanced Colorectal Cancer

Phase 2 Completed

62 enrolled

Gastrointestinal

Carcinoma, Colonic Neoplasms, Neoplasms, Colorectal Neoplasms

NCT00035165 2012-04-25

EPO906 Therapy in Patients With Advanced Melanoma

Phase 2 Completed

51 enrolled

Dermatologic

Melanoma, Neoplasm Metastasis, Neoplasms

NCT00035243 2012-04-17

EPO906 Therapy in Patients With Advanced Kidney Cancer

Phase 2 Completed

53 enrolled

Genitourinary

Carcinoma, Kidney Neoplasms, Neoplasms

NCT00035100 2012-04-16

EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer

Phase 2 Completed

54 enrolled

Gynecologic

Carcinoma, Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

Clinical Trials

Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer

Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer

EPO906 in Carcinoid and Other Neuroendocrine Tumors

EPO906 Therapy in Patients With Prostate Cancer

EPO906 Therapy in Patients With Advanced Breast Cancer

Patupilone Activity in Advanced/Metastatic Hepatocellular Carcinoma

EPO906 Therapy in Patients With Advanced Colorectal Cancer

EPO906 Therapy in Patients With Advanced Melanoma

EPO906 Therapy in Patients With Advanced Kidney Cancer

EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer